Table 3:
COVARIABLE | OVERALL SURVIVAL N=101 | PROGRESSION-FREE SURVIVAL N=101 | ||
---|---|---|---|---|
|
||||
Hazard Ratio (95% CI) | P | Hazard Ratio (95% CI) | P | |
PRE-TREATMENT LYMPHOCYTE COUNT | ||||
> 1.5 K/μL | Reference | Reference | - | |
≤ 1.5 K/μL | 2.85 (0.94, 8.62) | 0.06 | 1.72 (0.69, 4.31) | 0.25 |
IG-IMRT | ||||
NO | Reference | Reference | - | |
YES | 0.76 (0.23, 2.49) | 0.66 | 0.98 (0.41, 2.35) | 0.97 |
AGE (PER 10 YEARS) | 1.06 (0.69, 1.63) | 0.79 | 0.91 (0.64, 1.29) | 0.60 |
FIGO STAGE | ||||
STAGE I-IIA | Reference | Reference | - | |
STAGE IIB | 0.54 (0.16, 1.89) | 0.34 | 0.75 (0.28, 2.04) | 0.58 |
STAGE III-IVA | 1.07 (0.19, 6.14) | 0.94 | 0.76 (0.18, 3.20) | 0.71 |